MAP1LC3A and hepatocellular carcinoma: These results were confirmed by the LC3 conversion and SQSTM1/p62 degradation experiments in HCC-LM3 cells by using two other LV-shASPP2 (LV-shASPP2#2, LV-shASPP2#3) (Supplementary Figure 2A).